EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study
R. Lewis (Sheffield (South Yorkshire), United Kingdom), I. Armstrong (Sheffield (South Yorkshire), United Kingdom), C. Bergbaum (London, United Kingdom), M. Brewis (Glasgow, United Kingdom), J. Cannon (Cambridge, United Kingdom), A. Charalampopoulos (Sheffield (South Yorkshire), United Kingdom), A. Church (Glasgow, United Kingdom), J. Coghlan (London, United Kingdom), R. Davies (London, United Kingdom), K. Dimopoulos (London, United Kingdom), C. Elliot (Sheffield, United Kingdom), J. Gibbs (London, United Kingdom), W. Gin-Sing (London, United Kingdom), G. Haji (London, United Kingdom), A. Hameed (Sheffield (South Yorkshire), United Kingdom), L. Howard (London, United Kingdom), M. Johnson (Glasgow, United Kingdom), A. Kempny (London, United Kingdom), D. Kiely (Sheffield (South Yorkshire), United Kingdom), F. Lo Giudice (Manchester, United Kingdom), C. Mccabe (London, United Kingdom), O. Peleyeju (London, United Kingdom), J. Pepke-Zaba (Cambridge, United Kingdom), G. Polwarth (Cambridge, United Kingdom), L. Price (London, United Kingdom), I. Sabroe (Sheffield (South Yorkshire), United Kingdom), B. Schreiber (London, United Kingdom), K. Sheares (Cambridge, United Kingdom), D. Taboada (Cambridge, United Kingdom), A. Thompson (Sheffield (South Yorkshire), United Kingdom), M. Toshner (Cambridge, United Kingdom), I. Wanjiku (London, United Kingdom), S. Wort (London, United Kingdom), J. Yorke (Manchester, United Kingdom), R. Condliffe (Sheffield (South Yorkshire), United Kingdom)
Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension
Disease area: Pulmonary vascular diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Lewis (Sheffield (South Yorkshire), United Kingdom), I. Armstrong (Sheffield (South Yorkshire), United Kingdom), C. Bergbaum (London, United Kingdom), M. Brewis (Glasgow, United Kingdom), J. Cannon (Cambridge, United Kingdom), A. Charalampopoulos (Sheffield (South Yorkshire), United Kingdom), A. Church (Glasgow, United Kingdom), J. Coghlan (London, United Kingdom), R. Davies (London, United Kingdom), K. Dimopoulos (London, United Kingdom), C. Elliot (Sheffield, United Kingdom), J. Gibbs (London, United Kingdom), W. Gin-Sing (London, United Kingdom), G. Haji (London, United Kingdom), A. Hameed (Sheffield (South Yorkshire), United Kingdom), L. Howard (London, United Kingdom), M. Johnson (Glasgow, United Kingdom), A. Kempny (London, United Kingdom), D. Kiely (Sheffield (South Yorkshire), United Kingdom), F. Lo Giudice (Manchester, United Kingdom), C. Mccabe (London, United Kingdom), O. Peleyeju (London, United Kingdom), J. Pepke-Zaba (Cambridge, United Kingdom), G. Polwarth (Cambridge, United Kingdom), L. Price (London, United Kingdom), I. Sabroe (Sheffield (South Yorkshire), United Kingdom), B. Schreiber (London, United Kingdom), K. Sheares (Cambridge, United Kingdom), D. Taboada (Cambridge, United Kingdom), A. Thompson (Sheffield (South Yorkshire), United Kingdom), M. Toshner (Cambridge, United Kingdom), I. Wanjiku (London, United Kingdom), S. Wort (London, United Kingdom), J. Yorke (Manchester, United Kingdom), R. Condliffe (Sheffield (South Yorkshire), United Kingdom). EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multi-centre study. 3973
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study Source: Eur Respir J, 57 (2) 2000124; 10.1183/13993003.00124-2020 Year: 2021
Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020 Year: 2021
Assessing quality of life of idiopathic pulmonary fibrosis patients: the INSTAGE study Source: Breathe, 15 (2) 144; 10.1183/20734735.0016-2019 Year: 2019
Impact of macitentan on the health-related quality of life (HRQoL) in pulmonary arterial hypertension (PAH): Results from a long-term randomised controlled trial Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment Year: 2013
Determinants of self-efficacy in patients with pulmonary arterial hypertension: A pilot study Source: International Congress 2016 – Treatment and assessment of functional outcomes in cardiorespiratory physiotherapy Year: 2016
Health-related quality of life and functional status in end-stage COPD: a longitudinal study Source: Eur Respir J 2011; 37: 280 Year: 2011
Health-related quality of life of patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis Source: Eur Respir Rev, 29 (158) 200154; 10.1183/16000617.0154-2020 Year: 2020
Assessment of quality of life and social and economic impact of the disease in patients with pulmonary arterial hypertension in Germany – Data of the SANTANA-Study Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020
EmPH asis-10 is associated with clinical outcome measures in pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment Year: 2013
The assessment of life expectancy of patients with primary pulmonary hypertension (PPH) Source: Eur Respir J 2003; 22: Suppl. 45, 582s Year: 2003
Health-related quality of life in patients with chronic obstructive pulmonary disease: effects of hospital-based home-care programme Source: Annual Congress 2009 - Pulmonary rehabilitation: extending the scope and benefit of rehabilitation for patients with chronic respiratory disease Year: 2009
Edu-Care®, a randomised, multicentre study on education and quality of life in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2002; 20: Suppl. 38, 211s Year: 2002
Does ambulatory oxygen improve quality of life in patients with fibrotic lung disease? Results from the AmbOx trial Source: Breathe, 15 (2) 140; 10.1183/20734735.0002-2019 Year: 2019
STARMAP: an observational study to assess disease-relevant outcomes using home-monitoring devices in patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019
The prevalence of poor sleep quality and its associated factors in patients with interstitial lung disease: a cross-sectional analysis Source: ERJ Open Res, 5 (3) 00062-2019; 10.1183/23120541.00062-2019 Year: 2019
Psychological functioning and lifestyle behaviours of patients with idiopathic pulmonary fibrosis: a prospective study Source: Virtual Congress 2021 – Psychological and behavioural issues in respiratory care Year: 2021
Properties of the COPD assessment test in a cross-sectional European study Source: Eur Respir J 2011; 37: 29-35 Year: 2011
The effect of pulmonary rehabilitation on health-related quality of life in patients with pulmonary sarcoidosis Source: International Congress 2018 – Telehealth, home rehabilitation and specific adaptations to exercise interventions in different settings Year: 2018
Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015
Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment Year: 2013